BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
ID: CBRND-BAA-22-01Type: Solicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW6QK ACC-APGABERDEEN PROVING GROU, MD, 21010-5424, USA

PSC

NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH (AC12)

Original Source

https://sam.gov/opp/66870bda25274773b3e5fa7cfd3c0e11/view
Timeline
    Description

    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.

    Point(s) of Contact
    Richard Totten
    (301) 619-2446
    richard.w.totten2.civ@army.mil
    Files
    Title
    Posted
    W911SR-22-R-CBRND BAA 11 Jun 22.pdf
    The Army Contracting Command at Aberdeen Proving Ground has issued a Broad Agency Announcement (BAA) for research and development efforts supporting the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND). Proposals are solicited from eligible organizations, including educational institutions and private industry, focusing on advanced medical countermeasures and enabling technologies for CBRN threats, with awards potentially involving procurement contracts, grants, or other transaction agreements. The announcement provides comprehensive guidelines for proposal submission, evaluation criteria, and administrative details for applicants.
    Similar Opportunities
    JPEO-CBRND CWMD BOTAA-24-01
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEPT OF THE ARMY: The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is seeking funding through Other Transaction Authority agreements (OTAs) for prototype and follow-on production projects within JPEO-CBRND mission areas of interest. The service being procured is the development of enabling technologies that speed up the advanced development process. This opportunity is open to all eligible sources, including educational institutions, nonprofit organizations, and private industry. Proposals are to be submitted in accordance with the provided guidelines. For more information, please refer to the JPEO-CBRND website.
    BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE) DEFENSE EFFORTS UNDER PROCUREMENT CONTRACTS, COOPERATIVE AGREEMENTS, AND PROTOTYPES UNDER OTHER TRANSACTIONS AGREEMENTS
    Active
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), is soliciting proposals through a Broad Agency Announcement (BAA) for innovative solutions in chemical, biological, radiological, nuclear, and explosive (CBRNE) defense capabilities. The BAA invites participation from a wide range of eligible sources, including educational institutions, nonprofit organizations, and private industry, to develop technologies such as sensor systems, aerosol technologies, and decontamination methods. This initiative is crucial for enhancing national defense capabilities and ensuring the Joint Warfighters' effectiveness on the battlefield and in homeland defense. Interested parties can submit preproposals at any time, with contact points for inquiries being Marc Lukaszewicz at marc.s.lukaszewicz.civ@army.mil and Lionel Love at lionel.d.love.civ@army.mil.
    RFI JPEO CBRND/JPL EB 2024 CBD S&T Conference 1:1 Sessions
    Active
    Dept Of Defense
    The Department of Defense, specifically the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO CBRND), is hosting a Request for Information (RFI) for capabilities that enable Chemical, Biological, Radiological, and Nuclear Defense (CBRND) during the Chemical and Biological Defense Science & Technology (CBD S&T) Conference scheduled for December 2-5, 2024, in Fort Lauderdale, Florida. The JPEO CBRND is particularly interested in technologies related to developmental and/or FDA-approved prophylactics and therapeutics that have completed Phase 1 clinical trials and demonstrated efficacy for a CB indication, as well as technologies that expedite the development and production of prophylactics, therapeutics, and diagnostics. This initiative is crucial for enhancing the Department of Defense's preparedness and response capabilities against potential biological threats. Interested parties are encouraged to register for a meeting slot via the JETT registration page at https://jacks.jpeocbrnd.army.mil/JETT, and for further inquiries, they can contact Allison Pizzo at allison.m.pizzo.civ@army.mil or call 520-671-1593.
    RFI-Transportable Patient Biocontainment, Isolation, and Quarantine Systems
    Active
    Dept Of Defense
    The U.S. Department of Defense seeks innovative solutions for its Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Protection (JPM CBRN Protection) program. The requirement is for transportable biocontainment, isolation, and quarantine (BIQ) systems, or components thereof, to be used across various platforms such as ships, aircraft, wheeled vehicles, and field deployable systems. These systems are crucial in preventing the spread of biological threats and addressing public health emergencies. Modularity, scalability, and compatibility with existing healthcare infrastructure are key attributes the government seeks, along with strict adherence to safety and quality standards. The focus is on finding deployable and sustainable solutions to contain hazardous pathogens, with the potential for multiple system applications across different platforms. An upcoming Innovation Day on October 9th, 2024, will provide an opportunity for interested parties to discuss their technologies and gain a deeper understanding of the government's requirements. Per the request, responses must be submitted via email to Brian Liska at brian.liska@usmc.mil by November 8th, 2024, at 5:00 p.m. EST. The contact email is brian.liska@usmc.mil, and further details can be found on the SAM.gov website.
    RFI JPEO CBRND/JPM CBRN Medical 2024 CBD S&T Conference 1:1 Sessions
    Active
    Dept Of Defense
    The Department of Defense, specifically the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO CBRND), is seeking capabilities that enhance Chemical, Biological, Radiological and Nuclear Defense (CBRND) in preparation for the Chemical and Biological Defense Science & Technology (CBD S&T) Conference scheduled for December 2-5, 2024, in Fort Lauderdale, Florida. The office is particularly interested in technologies related to new vaccine platforms, host-directed therapeutics, medications effective for chemical or radiological injuries, and the potential repurposing of FDA-approved drugs for CBRN applications. These medical countermeasures are vital for developing innovative solutions to protect service members against CBRN threats. Interested parties are encouraged to register for one-on-one sessions via the JETT registration page and can reach out to Allison Pizzo at allison.m.pizzo.civ@army.mil or by phone at 520-671-1593 for further inquiries.
    RFI JPEO CBRND/JPM CBRN Sensors 2024 CBD S&T Conference 1:1 Sessions
    Active
    Dept Of Defense
    The Department of Defense, through the Joint Project Manager for Chemical, Biological, Radiological and Nuclear Defense (JPEO CBRND), is seeking innovative technologies for the detection, classification, and identification of CBRN hazards in preparation for the Chemical and Biological Defense Science & Technology (CBD S&T) Conference scheduled for December 2-5, 2024, in Fort Lauderdale, Florida. The objective is to engage with companies that possess capabilities to enhance CBRN situational awareness and address emerging threats, particularly through novel detection techniques and integrated sensor networks. This initiative is critical for ensuring timely and accurate information to support commanders in mitigating the risks associated with CBRN hazards on the battlefield. Interested parties are encouraged to register for one-on-one sessions via the JETT registration page and can contact Allison Pizzo at allison.m.pizzo.civ@army.mil or 520-671-1593 for further inquiries.
    2025 CB Warfighter Engagements
    Active
    Dept Of Defense
    The U.S. Department of Defense issues a Request for Information (RFI) to connect with industry and academic innovators. The goal is to accelerate the development of technologies that aid the warfighter in understanding, protecting against, and mitigating chemical, biological, and radiological (CBR) threats. The RFI seeks interest and solutions for three experimental events: Chemical Biological Operational Analysis (CBOA), a Concept Tent exhibition, and the Tenacious Dragon 3 (TD3) Advanced Technology Demonstration. These events, to be held in 2025, will evaluate submissions based on their relevance to CBR defense and the maturity of their designs. The need for robust CBR defense technologies is paramount in military operations, especially in detecting threats, ensuring force protection, and responding rapidly to hazardous incidents. The focus is on enhancing the capabilities of personnel operating in these dangerous environments, with specific attention to real-time detection, diagnostics, protective equipment, and rapid mitigation methods. Interested parties should submit their solutions, focusing on one capability area, by the deadline of December 12th, 2024, with an interim cutoff in September. Submissions require a Vulcan Scout Card and registration on the Vulcan platform, with industry and government affiliates following different guidelines.
    RFI JPEO CBRND/JPM CBRN SOF 2024 CBD S&T Conference 1:1 Sessions
    Active
    Dept Of Defense
    The Department of Defense, specifically the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO CBRND), is seeking capabilities that enhance Chemical, Biological, Radiological, and Nuclear Defense (CBRND) for Special Operations Forces (SOF). Interested parties are invited to participate in one-on-one sessions during the Chemical and Biological Defense Science & Technology (CBD S&T) Conference, scheduled for December 2-5, 2024, in Fort Lauderdale, Florida, to discuss technologies related to protection, detection, identification, and decontamination. This initiative is crucial for equipping SOF with the necessary CBRN defense equipment to ensure mission success in denied environments. Interested vendors should register for a meeting slot via the JETT registration page and can contact Allison Pizzo at allison.m.pizzo.civ@army.mil or 520-671-1593 for further information.
    RFI JPEO CBRND/JPM Integration 2024 CBD S&T Conference 1:1 Sessions
    Active
    Dept Of Defense
    The Department of Defense, specifically the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), is seeking capabilities that enhance Chemical, Biological, Radiological, and Nuclear Defense (CBRND) for the upcoming Chemical and Biological Defense Science & Technology (CBD S&T) Conference scheduled for December 2-5, 2024, in Fort Lauderdale, Florida. The focus is on technologies ready for advanced component development and prototypes that improve CBRN situational awareness, integrating CBRN defense systems with traditional defense systems to provide commanders with enhanced situational understanding of threats in the battlespace. Interested parties are encouraged to register for one-on-one sessions through the JETT registration page and can reach out to Allison Pizzo at allison.m.pizzo.civ@army.mil or by phone at 520-671-1593 for further inquiries.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is seeking proposals for extramural biomedical research and development. This opportunity is issued by the DEFENSE HEALTH AGENCY (DHA) under the BROAD AGENCY ANNOUNCEMENT (BAA) HT9425-23-S-SOC1. The purpose of this BAA is to solicit research and development ideas to advance the state-of-the-art or increase knowledge in the field. The projects funded under this BAA should focus on basic and applied research rather than the development of specific systems or hardware solutions. The research and development funding is expected to benefit both military and civilian medical practice and knowledge. Interested parties must submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If selected, the offeror will be invited to submit a full proposal or application through Grants.gov. The BAA is open for a 5-year period, from August 1, 2023, to July 31, 2028. The BAA with revised research areas of interest and General Submission Instructions can be found on Grants.gov using opportunity number HT9425-23-S-SOC1.